Phosphate Salts - Futibatinib Interaction Details

Interaction Details

Futibatinib is classified as belonging to the following category: Futibatinib (Lytgobi)

Taking futibatinib with phosphate salts increases the risk of hyperphosphatemia.
Futibatinib can cause hyperphosphatemia, as reported in 88% of patients in clinical studies. In addition, 77% of patients in clinical studies required use of a phosphate binder to manage hyperphosphatemia. Phosphate salts should generally be avoided by people taking this medication.

Interaction Rating

Major

Likelihood of Occurrence

Likely

Well-controlled human studies have demonstrated the likely existence of this interaction

References

Product information for Lytgobi. Taiho Pharmaceutical Co., Japan. September 2022.

Phosphate Salts - More Interactions

Phosphate Salts interacts with 12 drugs

Interaction Rating Key

These severity listings are for informational use only. Never start, stop or otherwise change your therapy before speaking with your provider.

Major	The combined use of these agents is strongly discouraged as serious side effects or other negative outcomes could occur.
Moderate	Use cautiously under the care of a healthcare professional or avoid this combination. A significant interaction or negative outcome could occur.
Minor	Be aware that there is a chance of an interaction. Watch for warning signs of a potential interaction.
Unknown	No interactions have been reported or no interaction data is currently available.